Authors
Wei Lyu, Weiping Cai, Yaokai Chen, Mengjie Han, Yun He, Huiqin Li, Linghua Li, Ruichao Lu, Ping Ma, Lijun Sun, Yongtao Sun, Hui Wang, Rugang Wang, Ning Wang, Hongxia Wei, Tong Zhang, Hongxin Zhao, Qingxia Zhao, Yingquan Zhou, Fujie Zhang, Taisheng Li
Published in
Infectious diseases & immunity. Volume 6. Issue 2. Pages 91-103. Epub Sep 29, 2025.
Abstract
With the advancement of combination antiretroviral therapy (cART), the global number of new human immunodeficiency virus (HIV) infections and HIV-related mortality has significantly declined. However, the high proportion of "late presentation" (defined as presenting to care with a low CD4 cell count or AIDS-defining events) among HIV-infected individuals remains a significant challenge in HIV prevention and treatment. HIV late presentation is associated with increased clinical risk, complex management, and higher risk of transmission, and represents a significant barrier to achieving the "95-95-95" targets and ending the HIV epidemic. Currently, both nationally and internationally, there is a lack of specific clinical guidelines for this population. Therefore, the China Association for Promotion of Health Science and Technology convened experts in the field to discuss the definition, clinical characteristics, risks, and cART of late presenters based on the latest research evidence and clinical practices both domestically and internationally. Specific recommendations were formulated to guide healthcare professionals in their clinical practice.
PMID:
42524606
Bibliographic data and abstract were imported from PubMed on 29 Jul 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 6
- Comments 0